Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, Neoplasm | 4 | 2021 | 1506 | 0.920 |
Why?
|
| BK Virus | 1 | 2023 | 123 | 0.880 |
Why?
|
| Cell- and Tissue-Based Therapy | 3 | 2023 | 406 | 0.850 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2023 | 489 | 0.810 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2023 | 211 | 0.760 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2023 | 427 | 0.680 |
Why?
|
| Salvage Therapy | 2 | 2021 | 2054 | 0.530 |
Why?
|
| Virus Diseases | 1 | 2019 | 398 | 0.520 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2024 | 6550 | 0.490 |
Why?
|
| T-Lymphocytes | 3 | 2023 | 3869 | 0.490 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2019 | 1016 | 0.470 |
Why?
|
| Monocytes | 1 | 2017 | 788 | 0.460 |
Why?
|
| Lymphoma | 1 | 2021 | 1467 | 0.420 |
Why?
|
| Dendritic Cells | 1 | 2017 | 1085 | 0.390 |
Why?
|
| Multiple Myeloma | 2 | 2020 | 2138 | 0.360 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2024 | 1586 | 0.230 |
Why?
|
| Herpesvirus 4, Human | 2 | 2023 | 966 | 0.200 |
Why?
|
| Microdialysis | 1 | 2021 | 50 | 0.200 |
Why?
|
| Immunity, Cellular | 1 | 2023 | 419 | 0.200 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2021 | 105 | 0.190 |
Why?
|
| Electrocorticography | 1 | 2021 | 72 | 0.190 |
Why?
|
| Electrodes, Implanted | 1 | 2021 | 183 | 0.190 |
Why?
|
| Lymphocyte Transfusion | 1 | 2021 | 175 | 0.190 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 423 | 0.170 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2021 | 181 | 0.160 |
Why?
|
| Airway Resistance | 1 | 2018 | 42 | 0.160 |
Why?
|
| Lymphocytes | 1 | 2023 | 1234 | 0.160 |
Why?
|
| Adenoviridae | 1 | 2023 | 1459 | 0.160 |
Why?
|
| Breathing Exercises | 1 | 2018 | 21 | 0.160 |
Why?
|
| Vaccination | 1 | 2023 | 1123 | 0.150 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 1320 | 0.140 |
Why?
|
| Humans | 14 | 2024 | 261506 | 0.140 |
Why?
|
| Cytomegalovirus | 1 | 2019 | 482 | 0.140 |
Why?
|
| Antiviral Agents | 1 | 2023 | 1230 | 0.140 |
Why?
|
| Respiration | 1 | 2018 | 447 | 0.130 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 675 | 0.130 |
Why?
|
| Antioxidants | 1 | 2018 | 507 | 0.120 |
Why?
|
| Graft vs Host Disease | 2 | 2022 | 2638 | 0.120 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2017 | 582 | 0.120 |
Why?
|
| Leukemia | 1 | 2022 | 1635 | 0.110 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2024 | 6915 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 1033 | 0.110 |
Why?
|
| Biomarkers | 3 | 2021 | 5047 | 0.110 |
Why?
|
| Exercise | 1 | 2018 | 1183 | 0.090 |
Why?
|
| Recurrence | 3 | 2024 | 4758 | 0.090 |
Why?
|
| Immunotherapy | 1 | 2023 | 3341 | 0.090 |
Why?
|
| Adult | 6 | 2022 | 77950 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2017 | 5637 | 0.080 |
Why?
|
| Cytokines | 1 | 2017 | 2809 | 0.080 |
Why?
|
| Young Adult | 3 | 2021 | 21445 | 0.080 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2021 | 2979 | 0.080 |
Why?
|
| Brain | 1 | 2021 | 4113 | 0.080 |
Why?
|
| Lung | 1 | 2018 | 3151 | 0.070 |
Why?
|
| Adolescent | 3 | 2021 | 31252 | 0.070 |
Why?
|
| Aged | 3 | 2021 | 70117 | 0.070 |
Why?
|
| Middle Aged | 3 | 2021 | 86204 | 0.060 |
Why?
|
| Male | 5 | 2021 | 123000 | 0.060 |
Why?
|
| Apoptosis | 1 | 2017 | 7591 | 0.060 |
Why?
|
| Prognosis | 1 | 2021 | 21713 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 13658 | 0.050 |
Why?
|
| Female | 4 | 2021 | 141928 | 0.050 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2021 | 107 | 0.050 |
Why?
|
| Monitoring, Immunologic | 1 | 2020 | 47 | 0.050 |
Why?
|
| Allografts | 1 | 2021 | 650 | 0.040 |
Why?
|
| Malondialdehyde | 1 | 2018 | 47 | 0.040 |
Why?
|
| CD56 Antigen | 1 | 2018 | 83 | 0.040 |
Why?
|
| HLA-DR Antigens | 1 | 2018 | 173 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 29902 | 0.040 |
Why?
|
| Receptors, IgG | 1 | 2018 | 102 | 0.040 |
Why?
|
| Leukocyte Common Antigens | 1 | 2018 | 188 | 0.040 |
Why?
|
| Transplant Recipients | 1 | 2020 | 324 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2021 | 769 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 486 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2024 | 2358 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2022 | 2843 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2020 | 1146 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2018 | 1681 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 2803 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2018 | 3033 | 0.020 |
Why?
|
| Child | 2 | 2022 | 29154 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 8865 | 0.020 |
Why?
|
| Time Factors | 1 | 2021 | 12926 | 0.020 |
Why?
|
| Phenotype | 1 | 2018 | 6295 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 10035 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 15862 | 0.010 |
Why?
|